2016 has been a tragedy-filled year for the most part. Terrorism runs wild, politicians and voters have lost their collective minds, and economies are still sluggish. But in the world of modafinil things have been cruising along beautifully. 2016 was a banner year for the smart drug. Not only are sales through the roof, but studies are pouring in revealing new applications for the nootropic giant.
As 2016 draws to a close, let’s take a look at some of the biggest developments for modafinil this year.
Modafinil’s cognitive benefits are real
No, it’s not just your mind playing tricks on you. For years students and professionals have been saying this. Well, in 2016, science caught up. One study proved that modafinil gave patients with depression a real improvement in memory function. Patients coming out of depression may have difficulty remembering things because they often walk around disinterested in what they’re doing. If you don’t care, you won’t remember. Modafinil helped them.
And for those totally healthy individuals, the majority of modafinil users, good news! A 2016 study confirmed that modafinil helped executive function and performance, meaning those results you see truly are real, and not placebo. The world’s first smart drug: Proven!
Modafinil can treat just about anything
Since modafinil cuts down fatigue like a chainsaw, researchers realized it could be a boon to so many other medical conditions. Fatigue makes it harder for people to recover. And in literally every trial, modafinil has helped.
Cancer patients? This 2016 study showed you were less likely to feel depressed and more likely to be active in your treatment.
Liver cirrhosis? Maybe you need a bigger dose than what this study tried. Virtually every successful trial has used at least 200mg. This one went easy on the patients with 100mg, and only saw light benefits.
Fibromyalgia? Modafinil can give you a normal life.
Look to 2017 as the year of clinical trials that put modafinil on the market for these conditions. Right now, these are just preliminary studies to test theories. But based on all the positive results, we can expect doctors to make it rain modafinil.
2016 showed Modafinil is safe
Wary of all the studies waving modafinil around like the cure-all panacea we’ve been searching for, some researchers tried to find some hazards. Tough sledding for these guys indeed.
Addiction is always a worry when doctors prescribe medication. The last thing you want is a patient that’s hooked forever. Modafinil time and again proves itself to be safe in this regard. A wide meta-analysis of dozens of studies showed that modafinil was the best option for patients.
Even children can take modafinil! Several 2016 studies experimented with using modafinil for ADHD and the results were excellent. Unlike amphetamine-based drugs like Ritalin or Adderall, modafinil was non-habit forming and didn’t reduce the children’s appetite as much. That’s a big win since a weak appetite could cause stunted growth.
Best of all, side effects are now completely understood and continue to be rare.
It’s been a great year for modafinil, and we know 2017 is only going to be better. With armodafinil undergoing studies, more phase 2 and 3 trials coming, and even the possibility of new formulations of modafinil, 2017 should be an amazing time for the world’s first true smart drug.